2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A
Advanced Rectal Cancer
li xiongSmall moleculePhase 2/3Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 40/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Advanced Rectal Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Tislelizumab brenner baruch | Phase 2 | CCC |
Same molecule, other indications
2-(1-HEXYLOXYETHYL)-2-DEVINYLPYROPHEOPHORBIDE-A is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →